Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Multiple Sclerosis

  Free Subscription


12.06.2017

1 BMC Neurol
2 J Immunol
1 J Neurol
1 J Neurol Neurosurg Psychiatry
1 J Neurosci Res
2 Lancet Neurol
1 Mayo Clin Proc
1 Mult Scler
2 Neurosci Lett


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. MUNSELL M, Frean M, Menzin J, Phillips AL, et al
    Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs.
    BMC Neurol. 2017;17:106.
    PubMed     Text format     Abstract available


    J Immunol

  2. MORANDI E, Jagessar SA, 't Hart BA, Gran B, et al
    EBV Infection Empowers Human B Cells for Autoimmunity: Role of Autophagy and Relevance to Multiple Sclerosis.
    J Immunol. 2017 Jun 7. pii: ji1700178. doi: 10.4049/jimmunol.1700178.
    PubMed     Text format     Abstract available

  3. LIN CC, Edelson BT
    New Insights into the Role of IL-1beta in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
    J Immunol. 2017;198:4553-4560.
    PubMed     Text format     Abstract available


    J Neurol

  4. HAGSTROM IT, Schneider R, Bellenberg B, Salmen A, et al
    Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.
    J Neurol. 2017 Jun 9. doi: 10.1007/s00415-017-8537.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  5. ZALEWSKI NL, Morris PP, Weinshenker BG, Lucchinetti CF, et al
    Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders.
    J Neurol Neurosurg Psychiatry. 2017;88:218-225.
    PubMed     Text format     Abstract available


    J Neurosci Res

  6. YONG H, Chartier G, Quandt J
    Modulating inflammation and neuroprotection in multiple sclerosis.
    J Neurosci Res. 2017 Jun 5. doi: 10.1002/jnr.24090.
    PubMed     Text format     Abstract available


    Lancet Neurol

  7. CHAN D, Binks S, Nicholas JM, Frost C, et al
    Effect of high-dose simvastatin on cognitive, neuropsychiatric, and health-related quality-of-life measures in secondary progressive multiple sclerosis: secondary analyses from the MS-STAT randomised, placebo-controlled trial.
    Lancet Neurol. 2017 Jun 6. pii: S1474-4422(17)30113.
    PubMed     Text format     Abstract available

  8. FILIPPI M, Rocca MA
    Simvastatin and cognition in multiple sclerosis.
    Lancet Neurol. 2017 Jun 6. pii: S1474-4422(17)30162.
    PubMed     Text format    


    Mayo Clin Proc

  9. WEINSHENKER BG, Wingerchuk DM
    Neuromyelitis Spectrum Disorders.
    Mayo Clin Proc. 2017;92:663-679.
    PubMed     Text format     Abstract available


    Mult Scler

  10. SATTARNEZHAD N, Farrow S, Kimbrough D, Glanz B, et al
    Agreement analysis comparing iPad LCVA and Sloan testing in multiple sclerosis patients.
    Mult Scler. 2017 Jun 1:1352458517713667. doi: 10.1177/1352458517713667.
    PubMed     Text format     Abstract available


    Neurosci Lett

  11. GIACOPPO S, Bereshchenko O, Bruscoli S, Riccardi C, et al
    Aberrant expression of beta-catenin in CD4+ T cells isolated from primary progressive multiple sclerosis patients.
    Neurosci Lett. 2017;653:159-162.
    PubMed     Text format     Abstract available

  12. SHIRVANI-FARSANI Z, Kakhki MP, Gargari BN, Doosti R, et al
    The expression of VDR mRNA but not NF-kappaB surprisingly decreased after vitamin D treatment in multiple sclerosis patients.
    Neurosci Lett. 2017;653:258-263.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: